A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
National Institutes of Health Clinical Center (CC)
Stanford University
Massachusetts General Hospital
University of California, San Francisco
University of Chicago
H. Lee Moffitt Cancer Center and Research Institute
Roswell Park Cancer Institute
St. Jude Children's Research Hospital
UNC Lineberger Comprehensive Cancer Center
M.D. Anderson Cancer Center
University of California, San Francisco
Sun Yat-sen University
St. Jude Children's Research Hospital
Stanford University
Fate Therapeutics
Baylor College of Medicine
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
Baylor College of Medicine
Anhui Provincial Hospital
The Affiliated People's Hospital of Ningbo University
Celyad Oncology SA